[HTML] springer.comFull View

[HTML][HTML] Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases

S Consalvi, V Saccone, L Giordani, G Minetti… - Molecular …, 2011 - Springer
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …
被引用次数：97 相关文章

Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases

S Consalvi, V Saccone, L Giordani… - Molecular …, 2011 - pubmed.ncbi.nlm.nih.gov
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …

Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases.

S Consalvi, V Saccone, L Giordani… - Molecular Medicine …, 2011 - europepmc.org
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …
[PDF] researchgate.net

[PDF][PDF] Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases

S Consalvi, V Saccone, L Giordani, G Minetti… - researchgate.net
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …

[引用][C] Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases

S Consalvi, V Saccone, L Giordani, G Minetti… - Molecular …, 2011 - cir.nii.ac.jp
Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for
Genetic Diseases | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[HTML] biomedcentral.com

[HTML][HTML] Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases

S Consalvi, V Saccone, L Giordani… - Molecular …, 2011 - molmed.biomedcentral.com
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …

Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases.

S Consalvi, V Saccone, L Giordani… - Molecular …, 2011 - search.ebscohost.com
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …
[HTML] nih.gov

[HTML][HTML] Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases

S Consalvi, V Saccone, L Giordani, G Minetti… - Molecular …, 2011 - ncbi.nlm.nih.gov
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …

Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases

S Consalvi, V Saccone, L Giordani, G Minetti… - MOLECULAR …, 2011 - iris.uniroma1.it
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …

Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases.

S Consalvi, V Saccone, L Giordani… - Molecular Medicine …, 2011 - europepmc.org
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the
ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical …